JEFF AMBROSO, PHD, DABT

Project Technical Lead

Jeffrey L. Ambroso, PhD, is a board-certified toxicologist with 18 years experience in pharmaceutical development at GlaxoSmithkline and RTI. He has expertise in nonclinical safety evaluation of drugs and biotechnology products including strategic planning, execution of a variety of toxicology studies, and regulatory submissions (INDs, NDAs). He has served as the preclinical safety representative on multiple project teams developing drugs for a variety of indications in both the private and public sector. Jeff is a member of the Society of Toxicology and an editorial board member for The International Journal of Toxicology. In his current position at RTI, he works closely with the TB Alliance and researchers in the public and private sector to develop novel treatments for tuberculosis, cancer, antibiotic-resistant bacterial infections and thrombosis.